A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit the Mcl-1 protein—an essential survival factor for therapy-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback